Psychemedics Names Brian Hullinger To Succeed Ray Kubacki As CEO Effective August 17, 2023
Portfolio Pulse from Benzinga Newsdesk
Psychemedics Corporation (PMD) has announced that Brian Hullinger will succeed Ray Kubacki as CEO effective August 17, 2023. Kubacki will retire from his current roles as Chairman of the Board, President, and CEO, but will remain with the company in an advisory role. Hullinger's appointment to the company's board of directors is subject to shareholder approval.
July 12, 2023 | 9:16 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Psychemedics Corporation (PMD) will see a change in leadership with Brian Hullinger taking over as CEO from Ray Kubacki on August 17, 2023. Kubacki will remain in an advisory role.
Leadership changes can have varying impacts on a company's stock. In this case, the outgoing CEO will remain in an advisory role, which may provide some stability during the transition. However, the market's reaction will largely depend on its perception of the incoming CEO, Brian Hullinger. As such, the short-term impact on PMD's stock is uncertain.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100